Niklas Hedberg's guest appearances

Niklas Hedberg

Vital Health Podcast

Hälso- och sjukvårdspodden

Fritt Fall

Ivor Cummins

Jeff Allen

Steve Rosenberg

Wilfred Reilly

John Murphy

John Doyle

Robert Madelin

Peter Young

Mark McClellan

Sarah Garner

Richard Evans

Chris Austin

Heidi Larson

Daniel Persson

Elin Haf Davies

OwlTail

TLVs chefsfarmaceut har många strängar på sin lyra både i Sverige och inom det europeiska samarbetet. Med lång erfarenhet och glimten i ögat far samtalet mellan många olika perspektiv med läkemedel som minsta gemensamma nämnare

Vi samtalar med Niklas Hedberg

Discusses OMPs

With the future of the EU HTA Regulation in question, Niklas Hedberg, Chair of the EUnetHTA Executive Board, discusses what’s needed to get the HTA Proposal back on track. Recorded at the HTAi conference in Köln, Niklas also expresses his opinions on the state of the OMP legislation from the standpoint of both EUnetHTA and his home HTA in Sweden, and does so incorporating the discussions around the orphan legislation at the conference. Niklas Hedberg is the Chief Pharmacist of the Swedish Pharmaceutical Benefits Agency (TLV) and a frequent presenter at leading conferences such as DIA and ISPOR. He is seen as one of Europe’s young visionaries, working to develop new approaches to evaluating medicines in the member states while also improving access for patients.See omnystudio.com/listener for privacy information.

With the future of the EU HTA Regulation in question, Niklas Hedberg, Chair of the EUnetHTA Executive Board, discusses what’s needed to get the HTA Proposal back on track. Recorded at the HTAi conference in Köln, Niklas also expresses his opinions on the state of the OMP legislation from the standpoint of both EUnetHTA and his home HTA in Sweden, and does so incorporating the discussions around the orphan legislation at the conference.<br/> <br/>Niklas Hedberg is the Chief Pharmacist of the Swedish Pharmaceutical Benefits Agency (TLV) and a frequent presenter at leading conferences such as DIA and ISPOR. He is seen as one of Europe’s young visionaries, working to develop new approaches to evaluating medicines in the member states while also improving access for patients.<p>See <a href="https://omnystudio.com/listener" rel="nofollow" target="_blank">omnystudio.com/listener</a> for privacy information.</p>

EUnetHTA’s Board Chair, Niklas Hedberg, Discusses OMPs and the EU HTA Review